BioFactura Raising Series B Investment to Advance Lead Biosimilar into Phase One Dr. Jeffrey Hausfeld, BioFactura’s Chairman of the Board and Chief Medical Officer has been tasked with raising a Series [….]
BioFactura Raising Series B Investment to Advance Lead Biosimilar into Phase One



